To amend the Harmonized Tariff Schedule for the United States to establish a new subheading in chapter 39 for silicone prosthetics for women who are breast cancer survivors and a new subheading in chapter 90 for mastectomy bras.
- Sponsor
- Rep. Miller, Carol D. [R-WV-1]
- Committees
- Ways and Means Committee (primary)
- Last action
- Aug 24, 2026
Bottom line
The bill aims to reduce the cost of essential post-mastectomy products for breast cancer survivors by eliminating import tariffs.
What it actually does
This bill amends the Harmonized Tariff Schedule of the United States (HTS) to eliminate import duties on two specific categories of goods: silicone prosthetic breast forms for use with mastectomy brassieres and mastectomy brassieres themselves. Effective January 1, 2027, these items would be classified under new, duty-free subheadings in Chapters 39 and 90 of the HTS, respectively.
Proponents argue
Proponents argue that this bill provides crucial financial relief to breast cancer survivors by making necessary medical devices and specialized apparel more affordable. They contend that removing tariffs on these items will reduce out-of-pocket expenses, improve access to products that aid in recovery and quality of life, and align tariff policy with public health priorities.
Opponents contend
Critics, if any, might raise concerns about the incremental loss of federal tariff revenue, arguing that while individually small, such reductions accumulate. Some might also suggest that while the intent is laudable, tariff policy is not the most efficient or targeted mechanism for healthcare cost reduction, preferring direct subsidies or insurance coverage mandates.
The bill is very short and clear, making it highly accessible for any reader to understand its provisions quickly.
Section 1
Duty-Free Silicone Prosthetic Breast Forms
This section amends Chapter 39 of the Harmonized Tariff Schedule of the United States to create a new subheading, 3926.20.61, specifically for 'Silicone prosthetic breast forms for use with mastectomy brassieres.' Under this new classification, these items will be subject to a general duty rate of 0%, effectively making them duty-free upon import into the U.S. This change is scheduled to take effect on January 1, 2027.
Supporters argue
Proponents argue that making silicone breast prosthetics duty-free directly addresses a financial burden on breast cancer survivors, who often face significant medical expenses. They contend that these prosthetics are not luxury items but essential components of post-mastectomy care, contributing to physical and emotional well-being.
Critics contend
No specific opposition is typically raised against this provision, as the revenue impact is likely small and the benefit targets a vulnerable population. However, general arguments against tariff reductions could include concerns over potential impacts on domestic manufacturing (if any exists for these specific items) or the cumulative effect of lost tariff revenue.
Tradeoffs
The primary tradeoff is between a minor reduction in federal tariff revenue and the significant benefit of reducing healthcare-related costs for breast cancer survivors. It balances fiscal considerations with public health and patient access.
Section 2
Duty-Free Mastectomy Brassieres
This section amends Chapter 90 of the Harmonized Tariff Schedule of the United States to create a new subheading, 9021.10.60, specifically for 'Mastectomy brassieres.' Similar to the prosthetics, these specialized bras will also be subject to a general duty rate of 0% when imported into the U.S. This change is also scheduled to become effective on January 1, 2027.